Probiotics and Immune Function: Current Systematic Review

⚠️ IMPORTANT LEGAL NOTICE

These scientific studies are for informational purposes only.

The presented research results are NOT approved Health Claims under EU Regulation (EC) No 1924/2006. For product advertising, only Health Claims officially approved by EFSA may be used.

Non-approved Health Claims are legally inadmissible and may lead to warnings.

✅ Check approved claims: [EU Health Claims Register](https://ec.europa.eu/food/safety/labelling_nutrition/claims/register/public/)

---

## Summary

A comprehensive review by Wang Y et al. from 2024 examines the immunomodulatory properties of probiotics and was published in Frontiers in Immunology.

Study Background

This systematic review analyzes the effects of various probiotic strains on immune parameters and infection rates.

Key Findings

The study shows: - Strain-specific effects: Lactobacillus and Bifidobacterium most effective - Reduction of respiratory infections: 20-30% fewer colds - Immunomodulation: Improvement of NK cell activity - Dosage: At least 10^9 CFU per day

Methodology

As a systematic review, this work combines results from over 50 randomized controlled trials.

Practical Relevance for Dietary Supplement Manufacturers

These research results are relevant for: - Product development: Strain selection and combination - Study results: The research shows certain effects (no approved claims) - Dosage: At least 10 billion CFU - Stability: Enteric-coated encapsulation

Source

The full study is freely available on Europe PMC.

Authors: Wang Y, Zhao J, Zhang H, Chen W Year: 2024 Journal: Frontiers in Immunology PMCID: PMC10828924 PMID: 38313434

---

*Note: This summary is for informational purposes. The presented study results are not approved Health Claims. For detailed information, please consult the original source.*